{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:44:18Z","timestamp":1789058658644,"version":"build-2803163510"},"reference-count":32,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:p>\n                    <jats:bold>Context.\u2014<\/jats:bold>\n                    <jats:italic>CDH17<\/jats:italic>\n                    , which is expressed in the intestinal epithelium, is a novel oncogene involved in tumor invasion and metastasis. A panel consisting of cytokeratin (CK) 7, CD20, and CDX2 antibodies is typically used to diagnose gastrointestinal adenocarcinomas. However, studies have shown that CDH17 is a highly specific marker for gastrointestinal adenocarcinoma and may be important in clinical diagnosis.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Objective.\u2014<\/jats:bold>\n                    To evaluate the sensitivity and specificity of CDH17, CK20, and CDX2 antibodies in neoplastic tissues, with emphasis on colon, stomach, and esophageal gastrointestinal lineage.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Design.\u2014<\/jats:bold>\n                    Immunohistochemistry was performed with CDH17, CK20, and CDX2 antibodies on formalin-fixed, paraffin-embedded tissue microarrays from normal (n = 26) and neoplastic (n = 884) tissues.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results.\u2014<\/jats:bold>\n                    CDH17 immunostaining was positive in 97.3% (145 of 149) of colon adenocarcinomas, whereas CK20 and CDX2 stained positively in 88.6% (132 of 149) and 93.3% (139 of 149), respectively. In metastatic colon cancers, CDH17, CK20, and CDX2 positive staining was observed in 90.6% (29 of 32), 59.4% (19 of 32), and 81.3% (26 of 32) of cases, respectively. In stomach adenocarcinomas, CDH17 positively stained 64.0% (112 of 175) of tissues, compared to CK20 and CDX2, where staining was observed in only 24.6% (43 of 175) and 46.9% (82 of 175), respectively. In esophageal adenocarcinomas, CDH17, CK20, and CDX2 stained 38.7% (12 of 31), 25.8% (8 of 31), and 29% (9 of 31) of specimens, respectively. Low or no expression was observed in other neoplastic tissues, except pancreatic cancers, where CDH17 displayed higher expression than CK20 and CDX2.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusions.\u2014<\/jats:bold>\n                    CDH17 is a specific and more sensitive marker in the gastrointestinal tract than CK20 and CDX2. CDH17 may be especially valuable when gastrointestinal tumors are suspected in cancers of unknown primary.\n                  <\/jats:p>","DOI":"10.5858\/arpa.2015-0404-oa","type":"journal-article","created":{"date-parts":[[2016,12,28]],"date-time":"2016-12-28T14:59:52Z","timestamp":1482937192000},"page":"144-150","source":"Crossref","is-referenced-by-count":37,"title":["CDH17 Is a More Sensitive Marker for Gastric Adenocarcinoma Than CK20 and CDX2"],"prefix":"10.5858","volume":"141","author":[{"given":"David","family":"Altree-Tacha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian","family":"Tyrrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Haas","sequence":"additional","affiliation":[{"name":"From Chief Scientific Officer (Dr Altree-Tacha) and the Department of Research and Development (Dr Tyrrell), Biocare Medical, Concord, California; and the Department of Pathology, Mercy Health System, Janesville, Wisconsin (Dr Haas)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","reference":[{"issue":"11","key":"i1543-2165-141-1-144-b01","series-title":"Hum Pathol","first-page":"1078","article-title":"Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary","volume":"33","author":"Park \n              SY,","year":"2002","unstructured":"Park \n              SY, \n            \n            \n              Kim \n              HS, \n            \n            \n              Hong \n              EK, \n            \n            et al. \n          Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary. Hum Pathol. 2002;33(11):1078\u20131085."},{"issue":"3","key":"i1543-2165-141-1-144-b02","series-title":"Am J Surg Pathol","first-page":"303","article-title":"CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas","volume":"27","author":"Werling \n              RW,","year":"2003","unstructured":"Werling \n              RW, \n            \n            \n              Yaziji \n              H, \n            \n            \n              Bacchi \n              CE, \n            \n            et al. \n          CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol. 2003;27(3):303\u2013310."},{"key":"i1543-2165-141-1-144-b03","series-title":"Diagn Pathol","first-page":"9","article-title":"The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-\/20+ phenotype is more specific than CDX2 antibody","volume":"7","author":"Bayrak \n              R,","year":"2012","unstructured":"Bayrak \n              R, \n            \n            \n              Haltas \n              H, \n            \n            \n              Yenidunya \n              S, \n            \n            et al. \n          The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-\/20+ phenotype is more specific than CDX2 antibody. Diagn Pathol. 2012;7:9."},{"issue":"3","key":"i1543-2165-141-1-144-b04","series-title":"Pathol Res Pract","first-page":"156","article-title":"Cytokeratin 7 and cytokeratin 20 expression in colorectal adenocarcinomas","volume":"207","author":"Bayrak \n              R,","year":"2011","unstructured":"Bayrak \n              R, \n            \n            \n              Yenid\u00fcnya \n              S, \n            \n            \n              Haltas \n              H. \n            \n          \n          Cytokeratin 7 and cytokeratin 20 expression in colorectal adenocarcinomas. Pathol Res Pract. 2011;207(3):156\u2013160."},{"issue":"9","key":"i1543-2165-141-1-144-b05","series-title":"Mod Pathol","first-page":"962","article-title":"Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases","volume":"13","author":"Chu \n              P,","year":"2000","unstructured":"Chu \n              P, \n            \n            \n              Wu \n              E, \n            \n            \n              Weiss \n              LM. \n            \n          \n          Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol. 2000;13(9):962\u2013972."},{"issue":"11","key":"i1543-2165-141-1-144-b06","series-title":"Mod Pathol","first-page":"1379","article-title":"Cadherin-17 is a useful diagnostic marker for adenocarcinomas of the digestive system","volume":"21","author":"Su \n              MC,","year":"2008","unstructured":"Su \n              MC, \n            \n            \n              Yuan \n              RH, \n            \n            \n              Lin \n              CY, \n            \n            et al. \n          Cadherin-17 is a useful diagnostic marker for adenocarcinomas of the digestive system. Mod Pathol. 2008;21(11):1379\u20131386."},{"issue":"2","key":"i1543-2165-141-1-144-b07","series-title":"Am J Clin Pathol","first-page":"211","article-title":"Tissue-specific cadherin CDH17 is a useful marker of gastrointestinal adenocarcinomas with higher sensitivity than CDX2","volume":"138","author":"Panarelli \n              NC,","year":"2012","unstructured":"Panarelli \n              NC, \n            \n            \n              Yantiss \n              RK, \n            \n            \n              Yeh \n              MM, \n            \n            et al. \n          Tissue-specific cadherin CDH17 is a useful marker of gastrointestinal adenocarcinomas with higher sensitivity than CDX2. Am J Clin Pathol. 2012;138(2):211\u2013222."},{"issue":"8","key":"i1543-2165-141-1-144-b08","series-title":"Arch Pathol Lab Med","first-page":"1015","article-title":"Cadherin-17 and SATB2 are sensitive and specific immunomarkers for medullary carcinoma of the large intestine","volume":"138","author":"Lin \n              F,","year":"2014","unstructured":"Lin \n              F, \n            \n            \n              Shi \n              J, \n            \n            \n              Zhu \n              S, \n            \n            \n              Chen \n              Z, \n            \n            et al. \n          Cadherin-17 and SATB2 are sensitive and specific immunomarkers for medullary carcinoma of the large intestine. Arch Pathol Lab Med. 2014;138(8):1015\u20131026."},{"issue":"17","key":"i1543-2165-141-1-144-b09","series-title":"Clin Cancer Res","first-page":"6162","article-title":"Expression of Cdx2 and hepatocyte antigen in gastric carcinoma: correlation with histologic type and implications for prognosis","volume":"11","author":"Fan \n              Z,","year":"2005","unstructured":"Fan \n              Z, \n            \n            \n              Li \n              J, \n            \n            \n              Dong \n              B, \n            \n            et al. \n          Expression of Cdx2 and hepatocyte antigen in gastric carcinoma: correlation with histologic type and implications for prognosis. Clin Cancer Res. 2005;11(17):6162\u20136170."},{"issue":"5","key":"i1543-2165-141-1-144-b10","series-title":"Hum Pathol","first-page":"576","article-title":"Cytokeratin expression profile in gastric carcinomas","volume":"35","author":"Kim \n              MA,","year":"2004","unstructured":"Kim \n              MA, \n            \n            \n              Lee \n              HS, \n            \n            \n              Yang \n              HK, \n            \n            et al. \n          Cytokeratin expression profile in gastric carcinomas. Hum Pathol. 2004;35(5):576\u2013581."},{"issue":"11","key":"i1543-2165-141-1-144-b11","series-title":"Mod Pathol","first-page":"1421","article-title":"Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7","volume":"19","author":"Vang \n              R,","year":"2006","unstructured":"Vang \n              R, \n            \n            \n              Gown \n              AM, \n            \n            \n              Wu \n              LS, \n            \n            et al. \n          Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7. Mod Pathol. 2006;19(11):1421\u20131428."},{"issue":"3","key":"i1543-2165-141-1-144-b12","series-title":"Jpn J Clin Oncol","first-page":"208","article-title":"CK7, CK20, CDX2 and MUC2 immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma","volume":"40","author":"Shin \n              JH,","year":"2010","unstructured":"Shin \n              JH, \n            \n            \n              Bae \n              JH, \n            \n            \n              Lee \n              A, \n            \n            et al. \n          CK7, CK20, CDX2 and MUC2 immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma. Jpn J Clin Oncol. 2010;40(3):208\u2013213."},{"issue":"5","key":"i1543-2165-141-1-144-b13","series-title":"Mod Pathol. 201;","first-page":"725","article-title":"Distinguishing primary adenocarcinoma of the urinary bladder from secondary involvement by colorectal adenocarcinoma: extended immunohistochemical profiles emphasizing novel markers","volume":"26","author":"Rao \n              Q,","unstructured":"Rao \n              Q, \n            \n            \n              Williamson \n              SR, \n            \n            \n              Lopez-Beltran \n              A, \n            \n            et al. \n          Distinguishing primary adenocarcinoma of the urinary bladder from secondary involvement by colorectal adenocarcinoma: extended immunohistochemical profiles emphasizing novel markers.Mod Pathol. 201;26(5):725\u2013732."},{"issue":"11","key":"i1543-2165-141-1-144-b14","series-title":"Dis Colon Rectum","first-page":"1873","article-title":"The prognostic significance of E-cadherin and liver intestine-cadherin expression in colorectal cancer","volume":"50","author":"Kwak \n              JM,","year":"2007","unstructured":"Kwak \n              JM, \n            \n            \n              Min \n              BW, \n            \n            \n              Lee \n              JH, \n            \n            et al. \n          The prognostic significance of E-cadherin and liver intestine-cadherin expression in colorectal cancer. Dis Colon Rectum. 2007;50(11):1873\u20131880."},{"issue":"3","key":"i1543-2165-141-1-144-b15","series-title":"PLoS One","first-page":"e56959","article-title":"Targeting CDH17 suppresses tumor progression in gastric cancer by downregulating Wnt\/\u03b2-catenin signaling","volume":"8","author":"Qiu \n              HB,","year":"2013","unstructured":"Qiu \n              HB, \n            \n            \n              Zhang \n              LY, \n            \n            \n              Ren \n              C, \n            \n            et al. \n          Targeting CDH17 suppresses tumor progression in gastric cancer by downregulating Wnt\/\u03b2-catenin signaling. PLoS One. 2013;8(3):e56959."},{"issue":"7","key":"i1543-2165-141-1-144-b16","series-title":"Int J Gynecol Cancer","first-page":"1170","article-title":"Up-regulation of cadherin 17 and down-regulation of homeodomain protein CDX2 correlate with tumor progression and unfavorable prognosis in epithelial ovarian cancer","volume":"22","author":"Huang \n              LP,","year":"2012","unstructured":"Huang \n              LP, \n            \n            \n              Yu \n              YH, \n            \n            \n              Sheng \n              C, \n            \n            et al. \n          Up-regulation of cadherin 17 and down-regulation of homeodomain protein CDX2 correlate with tumor progression and unfavorable prognosis in epithelial ovarian cancer. Int J Gynecol Cancer. 2012;22(7):1170\u20131176."},{"issue":"11","key":"i1543-2165-141-1-144-b01","series-title":"Hum Pathol","first-page":"1078","article-title":"Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary","volume":"33","author":"Park \n              SY,","year":"2002","unstructured":"Park \n              SY, \n            \n            \n              Kim \n              HS, \n            \n            \n              Hong \n              EK, \n            \n            et al. \n          Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary. Hum Pathol. 2002;33(11):1078\u20131085."},{"issue":"3","key":"i1543-2165-141-1-144-b02","series-title":"Am J Surg Pathol","first-page":"303","article-title":"CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas","volume":"27","author":"Werling \n              RW,","year":"2003","unstructured":"Werling \n              RW, \n            \n            \n              Yaziji \n              H, \n            \n            \n              Bacchi \n              CE, \n            \n            et al. \n          CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol. 2003;27(3):303\u2013310."},{"key":"i1543-2165-141-1-144-b03","series-title":"Diagn Pathol","first-page":"9","article-title":"The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-\/20+ phenotype is more specific than CDX2 antibody","volume":"7","author":"Bayrak \n              R,","year":"2012","unstructured":"Bayrak \n              R, \n            \n            \n              Haltas \n              H, \n            \n            \n              Yenidunya \n              S, \n            \n            et al. \n          The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-\/20+ phenotype is more specific than CDX2 antibody. Diagn Pathol. 2012;7:9."},{"issue":"3","key":"i1543-2165-141-1-144-b04","series-title":"Pathol Res Pract","first-page":"156","article-title":"Cytokeratin 7 and cytokeratin 20 expression in colorectal adenocarcinomas","volume":"207","author":"Bayrak \n              R,","year":"2011","unstructured":"Bayrak \n              R, \n            \n            \n              Yenid\u00fcnya \n              S, \n            \n            \n              Haltas \n              H. \n            \n          \n          Cytokeratin 7 and cytokeratin 20 expression in colorectal adenocarcinomas. Pathol Res Pract. 2011;207(3):156\u2013160."},{"issue":"9","key":"i1543-2165-141-1-144-b05","series-title":"Mod Pathol","first-page":"962","article-title":"Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases","volume":"13","author":"Chu \n              P,","year":"2000","unstructured":"Chu \n              P, \n            \n            \n              Wu \n              E, \n            \n            \n              Weiss \n              LM. \n            \n          \n          Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol. 2000;13(9):962\u2013972."},{"issue":"11","key":"i1543-2165-141-1-144-b06","series-title":"Mod Pathol","first-page":"1379","article-title":"Cadherin-17 is a useful diagnostic marker for adenocarcinomas of the digestive system","volume":"21","author":"Su \n              MC,","year":"2008","unstructured":"Su \n              MC, \n            \n            \n              Yuan \n              RH, \n            \n            \n              Lin \n              CY, \n            \n            et al. \n          Cadherin-17 is a useful diagnostic marker for adenocarcinomas of the digestive system. Mod Pathol. 2008;21(11):1379\u20131386."},{"issue":"2","key":"i1543-2165-141-1-144-b07","series-title":"Am J Clin Pathol","first-page":"211","article-title":"Tissue-specific cadherin CDH17 is a useful marker of gastrointestinal adenocarcinomas with higher sensitivity than CDX2","volume":"138","author":"Panarelli \n              NC,","year":"2012","unstructured":"Panarelli \n              NC, \n            \n            \n              Yantiss \n              RK, \n            \n            \n              Yeh \n              MM, \n            \n            et al. \n          Tissue-specific cadherin CDH17 is a useful marker of gastrointestinal adenocarcinomas with higher sensitivity than CDX2. Am J Clin Pathol. 2012;138(2):211\u2013222."},{"issue":"8","key":"i1543-2165-141-1-144-b08","series-title":"Arch Pathol Lab Med","first-page":"1015","article-title":"Cadherin-17 and SATB2 are sensitive and specific immunomarkers for medullary carcinoma of the large intestine","volume":"138","author":"Lin \n              F,","year":"2014","unstructured":"Lin \n              F, \n            \n            \n              Shi \n              J, \n            \n            \n              Zhu \n              S, \n            \n            \n              Chen \n              Z, \n            \n            et al. \n          Cadherin-17 and SATB2 are sensitive and specific immunomarkers for medullary carcinoma of the large intestine. Arch Pathol Lab Med. 2014;138(8):1015\u20131026."},{"issue":"17","key":"i1543-2165-141-1-144-b09","series-title":"Clin Cancer Res","first-page":"6162","article-title":"Expression of Cdx2 and hepatocyte antigen in gastric carcinoma: correlation with histologic type and implications for prognosis","volume":"11","author":"Fan \n              Z,","year":"2005","unstructured":"Fan \n              Z, \n            \n            \n              Li \n              J, \n            \n            \n              Dong \n              B, \n            \n            et al. \n          Expression of Cdx2 and hepatocyte antigen in gastric carcinoma: correlation with histologic type and implications for prognosis. Clin Cancer Res. 2005;11(17):6162\u20136170."},{"issue":"5","key":"i1543-2165-141-1-144-b10","series-title":"Hum Pathol","first-page":"576","article-title":"Cytokeratin expression profile in gastric carcinomas","volume":"35","author":"Kim \n              MA,","year":"2004","unstructured":"Kim \n              MA, \n            \n            \n              Lee \n              HS, \n            \n            \n              Yang \n              HK, \n            \n            et al. \n          Cytokeratin expression profile in gastric carcinomas. Hum Pathol. 2004;35(5):576\u2013581."},{"issue":"11","key":"i1543-2165-141-1-144-b11","series-title":"Mod Pathol","first-page":"1421","article-title":"Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7","volume":"19","author":"Vang \n              R,","year":"2006","unstructured":"Vang \n              R, \n            \n            \n              Gown \n              AM, \n            \n            \n              Wu \n              LS, \n            \n            et al. \n          Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7. Mod Pathol. 2006;19(11):1421\u20131428."},{"issue":"3","key":"i1543-2165-141-1-144-b12","series-title":"Jpn J Clin Oncol","first-page":"208","article-title":"CK7, CK20, CDX2 and MUC2 immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma","volume":"40","author":"Shin \n              JH,","year":"2010","unstructured":"Shin \n              JH, \n            \n            \n              Bae \n              JH, \n            \n            \n              Lee \n              A, \n            \n            et al. \n          CK7, CK20, CDX2 and MUC2 immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma. Jpn J Clin Oncol. 2010;40(3):208\u2013213."},{"issue":"5","key":"i1543-2165-141-1-144-b13","series-title":"Mod Pathol. 201;","first-page":"725","article-title":"Distinguishing primary adenocarcinoma of the urinary bladder from secondary involvement by colorectal adenocarcinoma: extended immunohistochemical profiles emphasizing novel markers","volume":"26","author":"Rao \n              Q,","unstructured":"Rao \n              Q, \n            \n            \n              Williamson \n              SR, \n            \n            \n              Lopez-Beltran \n              A, \n            \n            et al. \n          Distinguishing primary adenocarcinoma of the urinary bladder from secondary involvement by colorectal adenocarcinoma: extended immunohistochemical profiles emphasizing novel markers.Mod Pathol. 201;26(5):725\u2013732."},{"issue":"11","key":"i1543-2165-141-1-144-b14","series-title":"Dis Colon Rectum","first-page":"1873","article-title":"The prognostic significance of E-cadherin and liver intestine-cadherin expression in colorectal cancer","volume":"50","author":"Kwak \n              JM,","year":"2007","unstructured":"Kwak \n              JM, \n            \n            \n              Min \n              BW, \n            \n            \n              Lee \n              JH, \n            \n            et al. \n          The prognostic significance of E-cadherin and liver intestine-cadherin expression in colorectal cancer. Dis Colon Rectum. 2007;50(11):1873\u20131880."},{"issue":"3","key":"i1543-2165-141-1-144-b15","series-title":"PLoS One","first-page":"e56959","article-title":"Targeting CDH17 suppresses tumor progression in gastric cancer by downregulating Wnt\/\u03b2-catenin signaling","volume":"8","author":"Qiu \n              HB,","year":"2013","unstructured":"Qiu \n              HB, \n            \n            \n              Zhang \n              LY, \n            \n            \n              Ren \n              C, \n            \n            et al. \n          Targeting CDH17 suppresses tumor progression in gastric cancer by downregulating Wnt\/\u03b2-catenin signaling. PLoS One. 2013;8(3):e56959."},{"issue":"7","key":"i1543-2165-141-1-144-b16","series-title":"Int J Gynecol Cancer","first-page":"1170","article-title":"Up-regulation of cadherin 17 and down-regulation of homeodomain protein CDX2 correlate with tumor progression and unfavorable prognosis in epithelial ovarian cancer","volume":"22","author":"Huang \n              LP,","year":"2012","unstructured":"Huang \n              LP, \n            \n            \n              Yu \n              YH, \n            \n            \n              Sheng \n              C, \n            \n            et al. \n          Up-regulation of cadherin 17 and down-regulation of homeodomain protein CDX2 correlate with tumor progression and unfavorable prognosis in epithelial ovarian cancer. Int J Gynecol Cancer. 2012;22(7):1170\u20131176."}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"link":[{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/141\/1\/article-p144.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/141\/1\/144\/1615536\/arpa_2015-0404-oa.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/141\/1\/article-p144.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/141\/1\/article-p144.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T01:09:09Z","timestamp":1770772149000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/141\/1\/article-p144.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":32,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.5858\/arpa.2015-0404-oa","relation":{},"ISSN":["0003-9985","1543-2165"],"issn-type":[{"value":"0003-9985","type":"print"},{"value":"1543-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}